Mendota Financial Group’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,224
Closed -$106K 201
2024
Q4
$106K Sell
2,224
-393
-15% -$20.2K 0.07% 95
2024
Q3
$150K Sell
2,617
-541
-17% -$31K 0.07% 84
2024
Q2
$165K Hold
3,158
0.09% 73
2024
Q1
$128K Sell
3,158
-160
-5% -$6K 0.08% 104
2023
Q4
$123K Hold
3,318
0.1% 131
2023
Q3
$127K Buy
+3,318
New +$136K 0.13% 74

Other funds holding HALO

Mendota Financial Group's HALO Position: Q1 2025 in Review

Mendota Financial Group sold out of Halozyme (HALO) in Q1 2025, closing a stake of 2,224 shares — an estimated $106K sold.

Mendota Financial Group first reported a position in HALO in Q3 2023 and held it in 6 quarters. The position peaked at $165K in Q2 2024. 550 funds tracked by Wall St. Rank hold HALO as of Q1 2025.

  • Mendota Financial Group reported no remaining Halozyme position as of Q1 2025 after selling out during the quarter.
  • Mendota Financial Group sold 2,224 Halozyme shares in Q1 2025, an estimated $106K.
  • Mendota Financial Group first reported a position in Halozyme in Q3 2023 and held it in 6 quarters.
  • Mendota Financial Group's Halozyme position peaked at $165K in Q2 2024.
  • 550 funds tracked by Wall St. Rank held Halozyme as of Q1 2025.

Based on Mendota Financial Group's 13F filing for Q1 2025, filed 22 Apr 2025.